Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 28, 2024 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
August 19, 2024 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Announces First Participants Dosed in MRT-6160 Phase 1 Study

Monte Rosa Therapeutics Announces First Participants Dosed in MRT-6160 Phase 1 Study
August 08, 2024 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Monte Rosa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
July 08, 2024 08:36 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day

Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day
June 27, 2024 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160

Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160
June 14, 2024 08:45 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis

Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis
May 30, 2024 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Announces Leadership Team Promotions

Monte Rosa Therapeutics Announces Leadership Team Promotions
May 30, 2024 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference

Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
May 21, 2024 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease

Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160
May 16, 2024 07:00 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering

Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right